(*Completed) The impact of COVID-19 vaccines in pregnancy, children and young people, and vulnerable groups (DaC-VaP-2) study.
The DaC-VaP-2 project works to use UK-wide data to study the uptake, safety and effectiveness of COVID-19 vaccines. It is an ongoing, EAVE II associated project.
Find out more at: 'What are connected projects?'
Find out more about our research: what we are doing, who we are working with and why it is important.
Meet our team
Hear more about the DaC-VaP-2 team, from our researchers and analysts, to our operations and PPIE personnel.
A summary of the publications members of the DaC-VaP-2 team have written or significantly contributed to. Our research is still ongoing, and expect more articles to be published soon.
Watch our webinar
On 22 September 2022, members of the DaC-VaP-2 team came together to deliver a webinar discussing the project's commitment to PPI, the national data assets involved and how they can be accessed, how the team developed their UK-wide analyses as well as international partnerships.
Visit the DaC-VaP research site
Visit the Vaccine Breakthroughs Project research site
Visit the Vaccine Booster Breakthroughs research site
Visit the COALESCE research site